| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/16/2001 | CA2400187A1 Protein c derivatives |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399436A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | CA2399402A1 Use of cyp1b1 inhibitors for treating cancer |
| 08/16/2001 | CA2399396A1 Tnf- .alpha. inhibitors |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399136A1 1h-imidazopyridine derivatives |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398840A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398567A1 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2398184A1 Method and compositions for treating an inflammatory disease |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2398007A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | CA2397993A1 Dehydroamino acids |
| 08/15/2001 | CN1308680A Genomic sequences upstream of the coding region of the G-CSF gene for protein production and delivery |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308632A 'Beta'-carboline compound |
| 08/15/2001 | CN1308631A Heterocyclic derivatives which inhibit factor xa |
| 08/15/2001 | CN1308629A Reduced partide size form of 1-(6-chloronaphth-2-ylsulphonyl)-4-[4-(4-pyridyl)benzoyl] piperazine |
| 08/15/2001 | CN1308625A Naphtho [2,3-b] heteroar-4-yl derivatives |
| 08/15/2001 | CN1308622A Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308618A Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| 08/15/2001 | CN1308616A Non-peptidyl inhibitors and VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory disease |
| 08/15/2001 | CN1308614A Benzimidazoles, production thereof and use thereof medicaments |
| 08/15/2001 | CN1308611A Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308544A Treatment for diabetes |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308538A Treatment of hyperproliferative disorders |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308535A Farnesyl protein transferase inhibitors for treating arthropathies |
| 08/15/2001 | CN1308534A Angiogenesis inhibitors |
| 08/15/2001 | CN1308533A Agent with an antidepressive effect |
| 08/15/2001 | CN1308531A Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies |
| 08/15/2001 | CN1308528A Plaster which contains steroids, and method for the production and use thereof |
| 08/15/2001 | CN1308492A Hypericin and i(hypericum) extract: specific T-type calcium channel blocker, and their use as T-type calcium channel targeted therapeutics |
| 08/15/2001 | CN1308086A Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 08/15/2001 | CN1308069A Substittued (dihydro)benzoxazole and (dihydro)benzoxazine compound and their preparation and medicine composite |
| 08/15/2001 | CN1307895A Injecta for promoting growth of pig |
| 08/15/2001 | CN1307886A Brain nourishing and intelligence promoting medicine and its preparation |
| 08/15/2001 | CN1307877A Plaster for cold |
| 08/15/2001 | CN1307872A Selenium product of natural marine organism and its preparation |
| 08/15/2001 | CN1307871A Goat fetus essence injecta and its preparation process |
| 08/15/2001 | CN1307870A Crystallized pirimiphos-methyl composite and its preparation and usage |
| 08/15/2001 | CN1069525C Turtle oil, soft-shelled turtle oil compositions and the preparation thereof |
| 08/15/2001 | CA2337381A1 Compositions and methods for treating osteoporosis |
| 08/14/2001 | US6274708 Mouse interleukin-11 receptor |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274633 NMDA antagonist |
| 08/14/2001 | US6274630 Administering polyamine |
| 08/14/2001 | US6274629 Use for 1,3-propanediol derivatives |
| 08/14/2001 | US6274624 Antiproliferative and neurotrophic molecules |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274616 ((3-(2-amino-1,2-dioxoethyl)-1-((1,1'-biphenyl)-3-ylmethyl)-2 -methyl-1h-indol-4-yl)oxy)acetic acid n,n-diethylglycolamidoester used for inhibiting human non-pancreatic secretory phopholipase a2 mediated release of |
| 08/14/2001 | US6274607 N-linked ureas and carbamates of heterocyclic thioesters |
| 08/14/2001 | US6274605 Administering an insulin sensitivity enhancer with an angiotensin converting enzyme inhibitor to reduce side effects to a diabetic patient |
| 08/14/2001 | US6274597 Method of enhancing lysosomal α-Galactosidase A |
| 08/14/2001 | US6274593 Treating psychological disorders, schizophrenia, and parkinson*s disease |
| 08/14/2001 | US6274588 4-phenyl-pyrimidine derivatives |
| 08/14/2001 | US6274581 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
| 08/14/2001 | US6274577 Autoimmune diseases; antiinflammatory agents |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/14/2001 | US6274149 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | CA2206824C Inhibitors of rotamase enzyme activity |
| 08/14/2001 | CA2198570C New derivatives of boronic acid, the process for producing said derivatives and the pharmaceutical compound that contain them |
| 08/14/2001 | CA2193310C 4-imidazolidinone compounds; process for preparing the same and pharmaceutical compositions containing them |
| 08/14/2001 | CA2158484C Novel benzopyrane derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/14/2001 | CA2148380C 5-arylindole derivatives |
| 08/14/2001 | CA2124083C Preparation of substituted piperidines |
| 08/14/2001 | CA1341284C Site-directed mutagenesis modified glycoprotein hormones and methods of use |
| 08/10/2001 | CA2331876A1 Water-soluble ligand-binding proteins and analogs of ligand-gated channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/09/2001 | WO2001057267A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
| 08/09/2001 | WO2001057265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
| 08/09/2001 | WO2001057242A2 Methods of protein destabilization and uses thereof |
| 08/09/2001 | WO2001057240A2 Interaction of nmda receptor with protein tyrosine phosphatase |
| 08/09/2001 | WO2001057226A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 08/09/2001 | WO2001057208A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof |
| 08/09/2001 | WO2001057194A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 08/09/2001 | WO2001057090A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody |
| 08/09/2001 | WO2001057078A1 Process for producing dialytic amyloid fiber polymerization nuclei, method of screening remedies for dialytic amyloidosis and remedies for dialytic amyloidosis |
| 08/09/2001 | WO2001057074A1 Ligands for fpr class receptors that induce a host immune response to a pathogen or inhibit hiv infection |
| 08/09/2001 | WO2001057067A1 Ligand for vascular endothelial growth factor receptor |
| 08/09/2001 | WO2001057060A1 Bcl-2-like polynucleotides, polypeptides, and antibodies |
| 08/09/2001 | WO2001057059A1 Antisense modulation of survivin expression |
| 08/09/2001 | WO2001057053A1 Method for preparing functionalised beta-(1,3)-glucan derivatives |
| 08/09/2001 | WO2001057044A1 Pyridoxazine derivatives |
| 08/09/2001 | WO2001057042A2 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/09/2001 | WO2001057039A1 Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of the 5-ht7 receptor |
| 08/09/2001 | WO2001057037A1 Platelet adp receptor inhibitors |
| 08/09/2001 | WO2001057036A1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057034A1 3-aminopyrazole inhibitors of cyclin dependent kinases |
| 08/09/2001 | WO2001057025A1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 08/09/2001 | WO2001057023A1 Heterocyclic amide derivatives |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |